Position in JNJ
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$2,603,192
+$48,794 QoQ
Shares Held
10,250
-1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#2,114
of 4,664 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kimelman & Baird, LLC holds $87,529,146 across 10 Drug Manufacturers - General names. JNJ ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
40,384 | $48,437,785 | |
| 2 | MRK |
Merck & Co., Inc.
|
160,179 | $20,583,001 | |
| 3 | ABBV |
AbbVie Inc.
|
30,656 | $7,714,275 | |
| 4 | AMGN |
Amgen Inc
|
14,240 | $5,156,588 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
10,250 | $2,603,192 | |
| 6 | NVS |
Novartis AG
|
6,850 | $1,073,532 | |
| 7 | PFE |
Pfizer Inc
|
42,976 | $1,034,862 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
15,525 | $894,550 |
All Filings in JNJ
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,603,192 | 10,250 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $2,554,398 | 10,450 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,151,452 | 10,396 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,927,626 | 10,396 | Shares | Sole | 2025-11-25 | |
| 2025-06-30 | $1,587,989 | 10,396 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,724,072 | 10,396 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,503,469 | 10,396 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,684,775 | 10,396 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,519,479 | 10,396 | Shares | Sole | 2024-08-19 | |
| 2021-06-30 | $1,614,452 | 9,800 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||